Newsletter

115180 - Qurient Co., Ltd.

115180 Summary

Biopharma

Stock Price & Overview

₩25,750 +2,700 (+11.71%) Close · Sep 7, 2026 KST

KOSDAQ | ₩KRW | Close: ₩25,750 ≈ US$18 · Market cap ₩1.0tn (≈ $690m)

Home › 115180 › Filings

Investor Relations Event

DART

Qurient Co., Ltd.

Filed Sep 7, 2026 KST · IR · receipt 20260907900175

kstock has not written this one up. The title above is a translation of the Korean form name; the filing itself is on DART, in Korean.

Read the original on DART ↗ Korean. DART is Korea's electronic disclosure system, run by the Financial Supervisory Service — the filing equivalent of EDGAR.

Korean form name: 기업설명회(IR)개최

115180

Price: ₩25,750
Change: +11.71%
Market cap: ₩1.0tn
Prev. close: ₩23,050

115180 Summary Compare to Peers

115180 data on kstock

Financials: 11 fiscal years
Valuation: Daily P/E, P/S, P/B, P/CF
Earnings: Eight quarters
Dividends: Per-share history

Every figure is taken from Qurient Co., Ltd.'s own DART filings and matched on IFRS account codes, so a line holds across years where the Korean wording changed.

More 115180 filings

115180 - Qurient Co., Ltd.

Investor Relations Event

115180

115180 data on kstock

More 115180 filings

Investor Relations Event

Securities registration statement (equity securities)

Material event report (paid-in capital increase)

Material matter affecting investment judgment (clinical trial plan approval)

Half-Year Report

5% Ownership Report — Large Holdings